EMA Is Exploring How Real-World Data Can Benefit Europe’s OTC Market, Says Agency Head Rasi

The European Medicines Agency is right now looking into how real-world data and evidence can be used to improve regulatory systems and extend access to OTC medicines within the European Union, the agency's executive director Guido Rasi told the recent AESGP Regulatory Conference in Amsterdam.

Real world data
Real-world data can be used to expand access to OTCs • Source: Shutterstock

More from Regulation

More from Policy & Regulation